it dropped out some middle sections.
i went and grabbed it.
Katie Barber (Host): Yeah, absolutely. And I don't see as many of those entry-level positions around now as we used to, which is a real shame. And I agree with you, I think it's definitely hard now for a lot of PhD graduates to find that move. But I love that you said you kind of stood in line and waited—really outside the comfort zone—but it sounded like you kind of gave yourself a little bit of confidence you needed to go ahead and do it. And I'd love to understand how your career kind of took off from there. So how long were you with Rho and then how did you progress on through regulatory affairs from there?
Navigating Leadership Roles from CROs to Biotech
Dr. Lauren Wilcoxen: So, you know, it's something I still tell people and I tell my kids, right, is you got to get comfortable with being uncomfortable. And so I would say even in my career early on at Rho, I would volunteer a lot, right? I would volunteer for opportunities and projects and positions and roles that maybe I wasn't fully qualified for, frankly, right? But I felt like I had enough so that I needed enough experience and then to at least try and then ask questions along the way and learn, right? And that was really how I sort of continued to grow pretty rapidly at Rho from a leadership perspective—worked my way from doing some regulatory writing and quality control and review of documents, very quickly progressing to being a leader of both regulatory submissions and regulatory projects, as well as clinical trials.
That taught me a ton, right? I was able to learn both what it's like to manage a clinical trial on a day-to-day basis—you have to be extremely detail-oriented and manage all of these different pieces—all the way up through how to understand how to build and execute on a regulatory strategy for a marketing application. And so that was incredibly valuable. I did work my way up. I got promoted a couple times at Rho and then it was interesting: Rho had, before I joined, disbanded departments a couple of years before I joined to have more of a flat organization, more of a project-based learning environment, leadership environment. And it was quite helpful in certain aspects because depending on the team and the project I was on, sometimes I would be leading the project, sometimes I'd be an individual contributor on the project, and you learn a lot in that way. However, I also felt like I had sort of gotten to a ceiling there where I wasn't really sure, other than continuing to take on more projects, what kind of trajectory I would have there as a leader.
And so I had been contacted by a recruiter for a position that was certainly more structured—more of the kind of traditional leadership structure environment that you would expect with departments and heads of departments. And it was a position to basically develop a department for US regulatory for PSI CRO, which is a global CRO. At this time Rho was really predominantly US-based, whereas PSI was global, was headquartered in Europe, and they had grown organically over time to be a global CRO. And it was also an opportunity to lead a department, to build a department, to build a team and processes and all of these things that I thought would help me grow. So I took that opportunity. About a week after I joined, they said, "Well, will you take over leadership of Canada regulatory as well?" Again, it's one of those themes where you get opportunities and you can either shy away or you can say, "Yeah, sure, I'll try that, and maybe I'll fail and maybe I won't, but either way, I'll learn from it." So that was that opportunity then to grow and lead a department and grow a team and build processes and SOPs and work with my colleagues cross-functionally all over the world. It was an incredible environment to grow and learn from.
And then again, I was sort of thinking about at that point: okay, what's next? Again, I was contacted by a recruiter for a position which was also very different and interesting in a lot of ways—working at Optum, part of UnitedHealth Group, to build a clinical research group there. That was a big company, much bigger than Rho and PSI which were more small-to-mid-sized CROs, and sort of almost building a mini-CRO within a healthcare company, right? So again, quite an interesting experience—building processes, building a team. I joined as Head of Regulatory and then was asked to take over program management and clinical as well. While I was there, I also helped to lead software development for a software that helped to identify patients for clinical trials based on electronic health record data.
So again, all of these interesting things I was learning and developing and experiencing, and then I utilized that experience to say: okay, I've done things on sort of the CRO side, the healthcare side—I really want to be on the sponsor side now. I really want to go and be part of the biotech environment and feel what it's like to own the products that I'm helping to bring to market. And so that drew me to an opportunity at Istari Oncology, which was a clinical-stage biotech focusing on immuno-oncology therapeutics. And so that was very interesting. The lead asset was a virus-based platform, which as a virologist and immunologist by training, that was interesting to me. And the program was really focused on glioblastoma and had been in the clinic for about a decade at the time. And they needed industry professionals to come in and figure out: okay, how do we take this program forward to hopefully get approval and commercialization?
And so that's where I came in again, to sort of build a regulatory department, to build processes, but also to really work through some of the early clinical data and develop that glioblastoma program, but also expand the program into other indications and try to build out that platform more. I came in and I grew that program across multiple solid tumors, multiple INDs. We had multiple meetings with FDA and progressed that forward. Unfortunately, this was sort of when I joined the company—it was during the COVID pandemic, early on during the pandemic... ...And again, it's an opportunity that I have really relished. I've grown a lot in the small environments, both from successes and sort of stepping stones through failures. And yeah, it's been very rewarding.
Essential Mindset for Thriving in Startup Biotech
Katie Barber (Host): What sort of advice would you have for someone who's looking to get into startup biotech for the first time? Particularly when it comes to mindset, right? It sounds like you and your team have that type of mindset. Like what advice would you give someone? What do they need to be prepared for?
Dr. Lauren Wilcoxen: Yeah, be prepared for the unknown, right? The ambiguity, the failures, the ups and downs. There's going to be periods of time where you're going to be incredibly busy and stressed. And then there's going to be other times where maybe there's some reprieve, right? And everything in between.
I think it's important to have goals when you're in a small company. Maybe you have an end goal of commercialization and commercializing yourself. Maybe your end goal is to be acquired. Maybe there's different kinds of goals that you have as a small company. Being comfortable with that as well—trying to be on the same page with what those goals are in leadership early on—is also important.
I think something that helped me, and I encourage folks that I talk to earlier in their careers or who are trying to make a career transition, is: take advantage of LinkedIn, take advantage of local networking organizations or local professional organizations. There's a local one here in North Carolina for regulatory affairs that helped me network, helped me meet new people, exposed me to different types of positions and different areas in the industry that I hadn't really thought about before. And I think that can be incredibly helpful if you are looking to enter into that phase, or maybe you're at a big company and you're like, "Well, what's it like as a startup?"
The best way is to ask questions. Very early in my career I was very uncomfortable with that—was not the person to go to those environments and conferences and networking events and really want to network. I would always think, "I don't know if I should talk to this person, and what do I say? I don't want to interrupt this group, and how do I start a conversation? This is so awkward, right?" And you just have to sort of be comfortable with being uncomfortable—go ahead and do it anyway and have the conversation. And they're probably feeling something similar to where you are, or maybe they did early on in their career and they understand, right? So at least sort of rip the band-aid off and try and have the conversation, and you never know where it'll lead.
So many of those conversations have led to friendships, have led to mentorships, have led to professional connections who maybe were one or two degrees removed from somebody else who I learned from or benefited from professionally. So I think again, be comfortable with being uncomfortable. Ask questions, talk to people in the position or in a company like one that you would like to work at to really try to peel back those layers—understand what you're getting into and understand the level of risk. If you're risk-intolerant, a startup environment is probably not for you, and that's okay, right? We all have different values. We all have different tolerances for risk, and so I think trying to understand that about yourself is really helpful, and some of these conversations can help with that as well.